← Research library

Natural and hybrid ("chimeric") stable regulatory glyproline peptides.

Review of earlier studies · 2005

What was studied
Developer synthesis of glyprolin research
Main finding
The developers described PGP-containing hybrid peptides as a way to combine regulatory activity with greater peptide stability. This historical framework does not transfer Semax or Selank outcomes to isolated PGP.

Study data at a glance

Participants or experimental model
Developer synthesis of glyprolin research
Reported results
The developers described PGP-containing hybrid peptides as a way to combine regulatory activity with greater peptide stability. This historical framework does not transfer Semax or Selank outcomes to isolated PGP.
Study limitations and source details

Study limitations

  • Review of a research program, not an independent trial.
  • Specific peptide origin, metabolism and clinical claims require original-source confirmation.

Source details

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Abstract reviewed

Sources checked

Citation

ReviewEnglish abstract

Ashmarin IP, Samonina GE, Lyapina LA, Kamenskii AA, Levitskaya NG, Grivennikov IA, Dolotov OV, Andreeva LA, Myasoedov NF. Natural and hybrid ("chimeric") stable regulatory glyproline peptides. Pathophysiology : the official journal of the International Society for Pathophysiology

Study source ↗ · DOI 10.1016/j.pathophys.2004.10.001 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards